Discovery & biology
Define disease-relevant targets, models, and the limitations of each experiment.
Our company
Built around a question
that deserves an answer.
What if a biotechnology company made life after Kernicterus its central scientific purpose?
The Kitheras vision
Discovery with direction.
Development with purpose.
We imagine a company built to translate promising science into treatments that matter.
In this future-state vision, Kitheras integrates discovery biology, translational neuroscience, clinical development, and patient insight around established bilirubin injury.
The ambition reaches beyond symptom management toward durable functional improvement and, ultimately, a cure. Each step must earn its place through evidence.
How the company works
Four disciplines.
One development engine.
Translational science
Connect biological activity with exposure, biomarkers, and functional questions.
Clinical development
Design appropriate studies with safety, meaningful endpoints, and independent oversight.
Patient perspective
Bring lived experience into priorities, study burden, and the definition of benefit.
Illustrative organizational model; no actual team members or facilities are represented.
A connected field
Different roles.
A shared human reason.
PIC-K provides a real-world reference point for prevention, education, and family support. cureKI’s founding vision centers on research and collaboration toward treatments. Kitheras imagines the company that could take promising therapeutic ideas through drug development.
These are distinct roles. This concept does not claim any affiliation, partnership, licensing relationship, or financial connection.
Build what comes next
A different future takes all of us.
Bring a discovery. Share a perspective. Help move the field forward.